Live
BioPharma DiveUniQure to file gene therapy for approval, reflecting major shifts at FDAEndpoints NewsUK waitlist for Novo's Wegovy pill triples in week after approval, major online pharmacy saysEndpoints NewsHackers claim they stole Novo Nordisk AI models, manufacturing recipesEndpoints NewsIn second reversal, FDA gives uniQure a green light to seek accelerated approvalBioPharma DiveJazz zeroes in on next-gen T cell engagers with AbCellera dealClinical OMICsVibrating Pill Predicts Anorexia RelapseFierceBiotechVedana Therapeutics surfaces with $46M to develop next generation of migraine prevention therapiesFierceBiotechUniQure stock surges after FDA U-turn clears path to gene therapy filingPharmaVoiceWhy ivermectin is in the limelight againClinical OMICsPhilippe Pouletty: Turning Europe’s Life Science Startups Into World LeadersBioWorldLundbeck patents new orexin OX2 receptor agonistsBioWorldZealand Pharma reports IL-23R antagonists
FierceBiotech Mar 19, 2026

Rare disease advocates stage 'funeral' at FDA, demand 4 actions of agency and Congress

Rare disease advocates stage 'funeral' at FDA, demand 4 actions of agency and Congress

Original
Body unavailable. Use the original source.